Zhuhai Rundu Pharmaceutical Co., Ltd. (SHE:002923)
10.15
-0.32 (-3.06%)
Jul 30, 2026, 1:35 PM CST
SHE:002923 Revenue
Zhuhai Rundu Pharmaceutical had revenue of 348.71M CNY in the quarter ending March 31, 2026, with 36.91% growth. This brings the company's revenue in the last twelve months to 1.27B, up 12.33% year-over-year. In the year 2025, Zhuhai Rundu Pharmaceutical had annual revenue of 1.18B, down -0.51%.
Revenue (ttm)
1.27B
Revenue Growth
+12.33%
P/S Ratio
2.76
Revenue / Employee
767.59K
Employees
1,655
Market Cap
3.51B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.18B | -6.00M | -0.51% |
| Dec 31, 2024 | 1.18B | -109.52M | -8.48% |
| Dec 31, 2023 | 1.29B | -80.35M | -5.86% |
| Jan 1, 2023 | 1.37B | 182.31M | 15.32% |
| Jan 1, 2022 | 1.19B | -62.70M | -5.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jinhe Biotechnology CO., LTD. | 2.99B |
| Zhejiang Starry Pharmaceutical | 2.47B |
| Tibet Weixinkang Medicine | 1.16B |
| Hunan Hansen Pharmaceutical | 1.03B |
| Qianjiang Yongan Pharmaceutical | 847.91M |
| Shandong Wohua Pharmaceutical | 784.94M |
| Shanghai Xiao Fang Pharmaceutical | 541.90M |
| Zhejiang Yatai Pharmaceutical | 318.16M |